News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,095 Results
Type
Article (86735)
Company Profile (703)
Press Release (763655)
Multimedia
Podcasts (139)
Webinars (18)
Section
Business (232773)
Career Advice (4130)
Deals (39748)
Drug Delivery (129)
Drug Development (91061)
Employer Resources (198)
FDA (18156)
Job Trends (17354)
News (396705)
Policy (39797)
Tag
Academia (3002)
Academic (2)
Accelerated approval (8)
Adcomms (32)
Allergies (103)
Alliances (56936)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (186)
Approvals (18106)
Artificial intelligence (371)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (376)
Cancer (2911)
Cardiovascular disease (235)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (36)
Cell therapy (550)
Cervical cancer (24)
Clinical research (74022)
Collaboration (1042)
Company closure (3)
Compensation (654)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (319)
Cystic fibrosis (117)
Data (2878)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (332)
Diagnostics (6962)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (166)
Drug pricing (148)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97418)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131253)
Executive appointments (885)
FDA (19762)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (948)
Gene editing (142)
Generative AI (36)
Gene therapy (417)
GLP-1 (899)
Government (5228)
Grass and pollen (6)
Guidances (180)
Healthcare (20911)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (37)
Infectious disease (3070)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (118)
Interviews (813)
IPO (17887)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (83)
Lung cancer (414)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (413)
MASH (92)
Medical device (14693)
Medtech (14698)
Mergers & acquisitions (22534)
Metabolic disorders (882)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (38)
Neuroscience (2248)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (47)
Obesity (466)
Opinion (286)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (297)
Patient recruitment (142)
Peanut (54)
People (65597)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22857)
Phase II (32144)
Phase III (24198)
Pipeline (1607)
Policy (221)
Postmarket research (3552)
Preclinical (10319)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (494)
Real estate (7398)
Recruiting (75)
Regulatory (27009)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (161)
Series B (107)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (89)
Vaccines (879)
Venture capitalists (51)
Weight loss (316)
Women's health (48)
Worklife (20)
Date
Today (118)
Last 7 days (542)
Last 30 days (2787)
Last 365 days (34262)
2025 (16634)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50422)
Australia (8864)
California (7471)
Canada (2305)
China (684)
Colorado (320)
Connecticut (338)
Delaware (192)
Europe (115686)
Florida (1104)
Georgia (255)
Hawaii (1)
Idaho (65)
Illinois (711)
India (32)
Indiana (373)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1070)
Massachusetts (5713)
Michigan (268)
Minnesota (467)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2083)
New Mexico (31)
New York (2102)
North Carolina (1211)
North Dakota (10)
Northern California (3222)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1600)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2755)
Tennessee (123)
Texas (1126)
United States (28245)
Utah (222)
Virginia (200)
Washington D.C. (80)
Washington State (659)
West Virginia (4)
Wisconsin (82)
There are 851,095 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nanotechnology Drug Delivery Market Size to Reach USD 228.82 Billion by 2032 on Back of Personalized Healthcare Advancements
June 18, 2025
·
1 min read
Press Releases
Digital Therapeutics Market to Expands at 27.8% CAGR to Attain USD 90.83 Billion by 2034
June 18, 2025
·
1 min read
Press Releases
Lenalidomide Drug Market to Reach USD 22.04 Bn by 2032 with A Growth Rate of 6.6% – Report by Coherent Market Insights
June 18, 2025
·
1 min read
Press Releases
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call
June 18, 2025
·
3 min read
Press Releases
Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma
June 18, 2025
·
7 min read
Press Releases
NervGen Announces Appointment of Randall Kaye, MD to Chief Medical Advisor Role
June 18, 2025
·
6 min read
Press Releases
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS)
June 18, 2025
·
1 min read
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
The new version of the bill will still need to go through the entire House and Senate.
June 18, 2025
·
2 min read
·
Tristan Manalac
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
Andembry is the first monthly Factor XIIa inhibitor for the prevention of HAE attacks and will be available to patients “before the end of June,” CSL announced.
June 18, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Lycia Cuts Staff More Than One Year After $106M Series C
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
June 18, 2025
·
143 min read
·
BioSpace Editorial Staff
1 of 85,110
Next
